ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Kilitch Drugs(I) Acquisition Worth ₹56.82 Cr

Kilitch Drugs rectified its October 22 board outcome on converting debt into material subsidiary KEB shares. Corrected terms: 1,66,471 shares at Rs 3,413.23 each, about Rs 56.82 Cr.

Key figures
Value₹56.82 Cr
Source

NSE filing, NSE: KILITCH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kilitch Drugs(I) Ltd: key numbers

Share price
₹200.61
Market cap
₹701.4 Cr
Revenue (annual)
₹235.5 Cr
Net profit (annual)
₹30.17 Cr
P/E (TTM)
29.1×Sector 43.8×
Promoter holding
63.77%+0.00% QoQ
FII holding
0.10%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kilitch Drugs(I) Ltd

All →

Other acquisition announcements

All →